Article Information
History
- December 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tingyan Wang1,2,
- David A Smith2,3,
- Cori Campbell1,2,
- Jolynne Mokaya1,
- Oliver Freeman2,4,
- Hizni Salih2,4,
- Anna L McNaughton1,
- Sarah Cripps5,
- Kinga A Várnai2,3,
- Theresa Noble2,3,
- Kerrie Woods2,3,
- Jane Collier6,
- Katie Jeffery7,
- Jim Davies2,8,
- Eleanor Barnes1,3,*,+ and
- Philippa C Matthews1,3,7,*
- 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- 2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
- 3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 4Nuffield Department of Population Health, Oxford, United Kingdom
- 5Pharmacy Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 6Department of Hepatology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 7Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 8Department of Computer Science, University of Oxford, Oxford, United Kingdom
- ↵+Corresponding author:
Professor Eleanor Barnes, email: ellie.barnes{at}ndm.ox.ac.uk
↵* Equal contribution
Posted December 14, 2020.
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
